Lunai Bioworks Inc. Current Assets
Lunai Bioworks Inc. (LNAI) had Current Assets of $3.73 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-05-15
- 2026-03-31: Assets, Current $3.73M.
- 2025-12-31: Assets, Current $514.49K.
- 2025-09-30: Assets, Current $800.36K.
- 2025-06-30: Assets, Current $1.05M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-03-31 | $3.73M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $514.49K 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $800.36K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.05M 10-Q · filed 2026-05-15 | |
| 2025-03-31 | $3.67M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.71M 10-Q · filed 2025-02-19 | |
| 2024-09-30 | $1.95M 10-Q/A · filed 2025-02-19 | |
| 2024-06-30 | $2.00M 10-K · filed 2025-09-29 | |
| 2024-03-31 | $1.22M 10-Q/A · filed 2025-02-19 | |
| 2023-12-31 | $2.40M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $1.91M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.57M 10-Q/A · filed 2025-02-19 | |
| 2023-03-31 | $3.93M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $5.39M 10-Q · filed 2023-03-09 | |
| 2022-09-30 | $8.13M 10-Q · filed 2023-03-07 | |
| 2022-06-30 | $9.57M 10-K · filed 2023-10-02 | |
| 2022-03-31 | $11.70M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $14.62M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $15.46M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $20.90M 10-K · filed 2023-02-27 | |
| 2021-03-31 | $4.92M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $4.01M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $6.07M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $8.94M 10-K · filed 2021-09-24 | |
| 2020-03-31 | $11.27M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $9.06M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $11.21M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $12.49M 10-K · filed 2020-09-23 | |
| 2019-03-31 | $10.51M 10-Q · filed 2019-05-16 | |
| 2018-12-31 | $13.27M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $13.55M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $15.76M 10-K · filed 2019-09-30 | |
| 2018-03-31 | $17.07M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $7.24M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $3.16M 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $4.20M 10-K · filed 2018-10-01 | |
| 2017-03-31 | $234.67K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $281.60K 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $784.56K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $732.48K 10-K · filed 2017-11-20 | |
| 2016-03-31 | $835.09K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $1.19M 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $1.57M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $1.91M 10-K · filed 2016-09-28 | |
| 2015-03-31 | $3.48M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $5.05M 10-KT · filed 2015-09-28 | |
| 2014-09-30 | $2.35M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $422.71K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $559.77K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $141.49K 10-KT · filed 2015-09-28 | $22.00 10-Q · filed 2014-02-11 |
| 2013-09-30 | $13.22K 10-Q · filed 2013-11-15 | |
| 2013-06-30 | $13.44K 10-Q · filed 2013-08-15 | |
| 2013-03-31 | $19.96K 10-Q · filed 2014-02-11 | |
| 2012-12-31 | $105.93K 10-Q · filed 2014-08-14 | $13.38K 10-Q · filed 2013-02-14 |
| 2012-09-30 | $15.52K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $13.55K 10-Q · filed 2012-08-20 | |
| 2012-03-31 | $13.55K 10-K · filed 2013-07-16 | |
| 2011-12-31 | $13.34K 10-Q · filed 2012-02-21 | |
| 2011-09-30 | $20.89K 10-Q · filed 2011-11-25 | |
| 2011-03-31 | $0.00 10-K · filed 2012-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |